Foreign body reactions are regularly seen as a late complication of cosmetic treatment with synthetic dermal fillers. Often this foreign body reaction is triggered by a systemic infection, but other systemic triggers are also reported. In this case report, we present a woman in her 60s who was treated with ipilimumab for metastatic melanoma. After two courses of treatment she developed painless facial nodules. A foreign body reaction to dermal fillers was suspected because the patient had received cosmetic treatment with dermal fillers 25 years previously. This reaction was confirmed by excision and histological examination. In the absence of other known triggers, this case revealed immunotherapy (ipilimumab) and subsequent activation of th...
As the list of anti-tumor immunotherapy agents and the list of cancers treated by these novel agents...
Antibodies directed against programmed death receptor 1 emerged as beneficial immune-checkpoint inhi...
Antibodies directed against programmed death receptor 1 emerged as beneficial immune-checkpoint inhi...
Foreign body reactions are regularly seen as a late complication of cosmetic treatment with syntheti...
Foreign body reactions are regularly seen as a late complication of cosmetic treatment with syntheti...
A 59 year old woman was diagnosed in 2012 with a superficial spreading melanoma of the left scapula....
A 59 year old woman was diagnosed in 2012 with a superficial spreading melanoma of the left scapula....
A 58-year-old female presented with 3 weeks history of painful skin lesion on the right cheek. Diagn...
BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors tar...
Ipilimumab is an immune-modulating drug that is being used today for various cancers including metas...
Ipilimumab is an immune-modulating drug that is being used today for various cancers including metas...
Ipilimumab and nivolumab are human monoclonal antibodies used in cancer therapy. Ipilimumab targets ...
BACKGROUND: Granulomatous reaction is a well-known complication following soft filler procedures. H...
Introduction: Polyacrylamide hydrogel has been considered a safe and biocompatible soft tissue fille...
BACKGROUND: Granulomatous reaction is a well-known complication following soft filler procedures. H...
As the list of anti-tumor immunotherapy agents and the list of cancers treated by these novel agents...
Antibodies directed against programmed death receptor 1 emerged as beneficial immune-checkpoint inhi...
Antibodies directed against programmed death receptor 1 emerged as beneficial immune-checkpoint inhi...
Foreign body reactions are regularly seen as a late complication of cosmetic treatment with syntheti...
Foreign body reactions are regularly seen as a late complication of cosmetic treatment with syntheti...
A 59 year old woman was diagnosed in 2012 with a superficial spreading melanoma of the left scapula....
A 59 year old woman was diagnosed in 2012 with a superficial spreading melanoma of the left scapula....
A 58-year-old female presented with 3 weeks history of painful skin lesion on the right cheek. Diagn...
BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors tar...
Ipilimumab is an immune-modulating drug that is being used today for various cancers including metas...
Ipilimumab is an immune-modulating drug that is being used today for various cancers including metas...
Ipilimumab and nivolumab are human monoclonal antibodies used in cancer therapy. Ipilimumab targets ...
BACKGROUND: Granulomatous reaction is a well-known complication following soft filler procedures. H...
Introduction: Polyacrylamide hydrogel has been considered a safe and biocompatible soft tissue fille...
BACKGROUND: Granulomatous reaction is a well-known complication following soft filler procedures. H...
As the list of anti-tumor immunotherapy agents and the list of cancers treated by these novel agents...
Antibodies directed against programmed death receptor 1 emerged as beneficial immune-checkpoint inhi...
Antibodies directed against programmed death receptor 1 emerged as beneficial immune-checkpoint inhi...